Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehmann, U.
Right arrow Articles by Kreipe, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehmann, U.
Right arrow Articles by Kreipe, H.
[Cancer Research 62, 6634-6638, November 15, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

Promoter Hypermethylation of the Death-associated Protein Kinase Gene in Breast Cancer Is Associated with the Invasive Lobular Subtype1

Ulrich Lehmann2, Gülhan Celikkaya, Britta Hasemeier, Florian Länger and Hans Kreipe

Institute of Pathology, Medizinische Hochschule Hannover, D-30625 Hannover, Germany

Expression of death-associated protein (DAP) kinase, a proapoptotic serine/threonine protein kinase, is frequently lost in human tumors. In a study of 134 primary breast cancer specimens hypermethylation of the DAP kinase gene was found in 13% of cases. A highly significant difference (P < 0.001) of DAP kinase inactivation was observed between invasive lobular cancer (n = 19) and invasive ductal cancer (n = 85; 53% versus 9%, respectively). Hypermethylation correlated with loss of RNA expression, estrogen receptor positivity (P < 0.01), and the absence of p53 overexpression (P < 0.01). In contrast to invasive lobular cancer, the in situ-growing precursor lesion lacked epigenetic modification of the DAP kinase promotor by aberrant methylation indicating a potential role in tumor progression. Unlike the DAP kinase gene, hypermethylation of the cyclin D1 and RASSF1A genes did not correlate with a particular histological subtype or to invasiveness. We conclude that different histological subtypes of breast cancer may not only differ concerning specific chromosomal abnormalities and DNA mutations but also with regard to epigenetic inactivation patterns.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Timmerbeul, C. M. Garrett-Engele, U. Kossatz, X. Chen, E. Firpo, V. Grunwald, K. Kamino, L. Wilkens, U. Lehmann, J. Buer, et al.
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer
PNAS, September 19, 2006; 103(38): 14009 - 14014.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Ai, W.-J. Kim, T.-Y. Kim, C. R. Fields, N. A. Massoll, K. D. Robertson, and K. D. Brown
Epigenetic Silencing of the Tumor Suppressor Cystatin M Occurs during Breast Cancer Progression
Cancer Res., August 15, 2006; 66(16): 7899 - 7909.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. A. Melnikov, R. B. Gartenhaus, A. S. Levenson, N. A. Motchoulskaia, and V. V. Levenson (Chernokhvostov)
MSRE-PCR for analysis of gene-specific DNA methylation
Nucleic Acids Res., June 8, 2005; 33(10): e93 - e93.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
U. Lehmann, I. Berg-Ribbe, L. U. Wingen, K. Brakensiek, T. Becker, J. Klempnauer, B. Schlegelberger, H. Kreipe, and P. Flemming
Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation Profiling
Clin. Cancer Res., May 15, 2005; 11(10): 3654 - 3660.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Dulaimi, J. Hillinck, I. I. de Caceres, T. Al-Saleem, and P. Cairns
Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients
Clin. Cancer Res., September 15, 2004; 10(18): 6189 - 6193.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Brakensiek, F. Langer, H. Kreipe, U. Lehmann, M. T. Voso, A. Scardocci, L. Valentini, F. Guidi, S. Hohaus, and G. Leone
Low level of DAP-kinase DNA methylation in myelodysplastic syndrome
Blood, September 1, 2004; 104(5): 1586 - 1588.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Levy, G. Plu-Bureau, Y. Decroix, D. Hugol, W. Rostene, A. Kimchi, and A. Gompel
Death-Associated Protein Kinase Loss of Expression Is a New Marker for Breast Cancer Prognosis
Clin. Cancer Res., May 1, 2004; 10(9): 3124 - 3130.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T.-S. Wong, D. L.-W. Kwong, J. S.-T. Sham, W. I. Wei, Y.-L. Kwong, and A. P.-W. Yuen
Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma
Clin. Cancer Res., April 1, 2004; 10(7): 2401 - 2406.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C.-M. Chen, H.-L. Chen, T. H.-C. Hsiau, A. H.-A. Hsiau, H. Shi, G. J. R. Brock, S. H. Wei, C. W. Caldwell, P. S. Yan, and T. H.-M. Huang
Methylation Target Array for Rapid Analysis of CpG Island Hypermethylation in Multiple Tissue Genomes
Am. J. Pathol., July 1, 2003; 163(1): 37 - 45.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.